explore -WSS

explore

author：focus 2025-10-01 00:16:46 - browse：2273

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： NASA releases new images of 'fingerprint

focus

explore

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Do digital therapeutics have a future in medicine?

Quicker fix for pulse oximeters urged during FDA public meeting

Trump pressured former Arizona governor to overturn 2020 election results: Sources

FDA drug safety: Singulair case shows systemic surveillance flaws

Apple Vision Pro: A first look at health apps on the new VR headset

focus

explore

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

General Catalyst, Summa Health deal will turn on physician buy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Quicker fix for pulse oximeters urged during FDA public meeting

Medical leaders decry Supreme Court decision on affirmative action

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Jerome Adams on the need for new antivirals for Covid

Medicare drug price negotiation’s day in court

In age of alternative facts, a scholarly course on calling out crap

Covid misinformation case heads to Supreme Court

focus

Congressmen charge Covid hearing ‘could have been an email’

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Some in Scotland's Orkney Islands want to return to Norway after 550 years

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

EU climate chief is concerned over the expansion of the coal industry in China

1 dead, 9 hurt in July 4th fireworks explosion

hotspot

focus

explore

hotspot